Feb 25th 2013 - Edison Investment Research today published a report on quickview entitled "Developing Deals". In summary, the report says:
Karolinska Development’s recent deals with a US VC firm, and separately with the renowned Mayo Clinic, should strengthen its financial position and boost its pipeline of future investment opportunities. Both are critical to its long-term future. However, in the near term, the investment case rests on its ability to execute either trade sales of portfolio companies or out-licensing deals, now that proof-of-concept data for a number of projects are, or will shortly, become available.
Edison Investment Research is a leading international investment research company. It has won industry recognition, with awards both in the UK and internationally. The team of 95 includes over 60 analysts supported by a department of supervisory analysts, editors and assistants. Edison writes on more than 400 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison’s research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. Edison, founded in 2003, has offices in London, New York and Sydney and is authorised and regulated by the Financial Services Authority (www.fsa.gov.uk/register/firmBasicDetails.do?sid=181584). more »